---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-043015"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2022-04-06T23:59:59+00:00"
generated_at: "2026-06-26T09:02:58.960030+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Collegium appoints Neil F. McFarlane to board; expands to nine directors

## Summary
- Board expanded from 8 to 9 members; McFarlane appointed effective April 6, 2022.
- Appointed director Neil F. McFarlane, 49, initial term until May 19, 2022 annual meeting.
- Annual cash retainer of $50k prorated; RSUs with grant date value of $337,500 vesting one year from grant.
- No family relationships or reportable related party transactions with existing directors/officers.
- No arrangement with any other person for selection as director.

## SEC filing metadata
- accession: 0001104659-22-043015
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2022-04-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465922043015/0001104659-22-043015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465922043015/tm2211650d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-043015
- JSON: https://secwatch.observer/filing/0001104659-22-043015.json
- Plain text: https://secwatch.observer/filing/0001104659-22-043015.txt

## Key facts
- Executive change
  Neil F. McFarlane was appointed as director at COLLEGIUM PHARMACEUTICAL, INC.
  - Action: appointed
  - Role: director
  source text: On April 6, 2022, the Board of Directors (the “Board”) of Collegium Pharmaceutical, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, expanded the size of the Board from eight to nine members and appointed Mr. Neil F. McFarlane, 49, as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1267565/000110465922043015/0001104659-22-043015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.